Is AMGN up or down today?
AMGN is down 1.34% today, last at 377.35. This stock moved -1.34% versus the prior close.
AMGN · Amgen
AMGN (Amgen) is trading at 377.35, down 1.34% on the session. AMGN sits at the 61% mark of its 52-week range, carries a 14-day RSI of 31, and trades below its 50-day average. Over the past month it is down 8.92%.
Leading the coverage: “Does Amgen (AMGN) Change The Oncology Case With This Phase 3 Survival Win? - simplywall.st” (Google News Company, 39m ago).
AMGN trades on a trailing P/E of 23.7 and is running 8.11% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
AMGN is down 1.34% today, last at 377.35. This stock moved -1.34% versus the prior close.
Leading the coverage: “Does Amgen (AMGN) Change The Oncology Case With This Phase 3 Survival Win? - simplywall.st” (Google News Company, 39m ago). Dominant story: Does Amgen (AMGN) Change The Oncology Case With This Phase 3 Survival Win? - simplywall.st (1 source, neutral) RSI is 31 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Does Amgen (AMGN) Change The Oncology Case With This Phase 3 Survival Win? - simplywall.st
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Amgen Drops 10% on a Trial It Didn't Even Run - MarketBeat
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?